Methods of using ajoene
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 5, 1999
Issued Date -
N/A
app pub date -
Jan 11, 1996
filing date -
Jun 30, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The progression of infection and other pathologies produced by a viral infection may be inhibited by administering an effective dosage of Ajoene. Additionally, Ajoene has anti-tumor, anti-shock, and anti-inflammation effects. In general, Ajoene may be used to treat any integrin-mediated disease or condition.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully